within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A05A_BileTherapy.A05AA02_UrsodeoxycholicAcid;

model UrsodeoxycholicAcid
  extends Pharmacolibrary.Drugs.ATC.A.A05AA02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A05AA02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Ursodeoxycholic acid (UDCA) is a secondary bile acid used for the treatment of primary biliary cholangitis (PBC) and certain cholestatic liver diseases. It works by reducing the absorption of cholesterol and protecting liver cells. It is an approved drug and remains the standard therapy for PBC and certain pediatric cholestatic conditions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers, both male and female, after single oral administration.</p><h4>References</h4><ol><li><p>Yoon, S, et al., &amp; Chung, JY (2021). Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function. <i>Clinical pharmacology in drug development</i> 10(1) 68–77. DOI:<a href=\"https://doi.org/10.1002/cpdd.790\">10.1002/cpdd.790</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/32191400/\">https://pubmed.ncbi.nlm.nih.gov/32191400</a></p></li><li><p>Roda, A, et al., &amp; Forti, GC (1991). Pharmacokinetics of ursodeoxycholic acid in rat. <i>Pharmacological research</i> 23(4) 327–335. DOI:<a href=\"https://doi.org/10.1016/1043-6618(91)90048-3\">10.1016/1043-6618(91)90048-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1876573/\">https://pubmed.ncbi.nlm.nih.gov/1876573</a></p></li><li><p>Yan, D, et al., &amp; Watanabe, H (2008). Effects of ursodeoxycholic acid on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam in healthy volunteers. <i>Naunyn-Schmiedeberg&#x27;s archives of pharmacology</i> 377(4-6) 629–636. DOI:<a href=\"https://doi.org/10.1007/s00210-007-0217-z\">10.1007/s00210-007-0217-z</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/18157519/\">https://pubmed.ncbi.nlm.nih.gov/18157519</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end UrsodeoxycholicAcid;
